share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga Real-time News ·  Jan 30, 2023 16:32

Gainers

  • Nymox Pharmaceutical (NASDAQ:NYMX) shares rose 21.8% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $45.2 million.
  • Brainstorm Cell (NASDAQ:BCLI) stock rose 10.83% to $1.93. The company's market cap stands at $70.6 million.
  • OKYO Pharma (NASDAQ:OKYO) stock moved upwards by 6.46% to $2.8. The company's market cap stands at $60.9 million.
  • Creative Medical Tech (NASDAQ:CELZ) stock rose 6.28% to $0.57. The market value of their outstanding shares is at $8.0 million.
  • Athenex (NASDAQ:ATNX) stock rose 5.44% to $0.19. The company's market cap stands at $29.8 million.
  • Virax Biolabs Group (NASDAQ:VRAX) stock moved upwards by 5.28% to $0.78. The company's market cap stands at $9.9 million.

Losers

  • Xilio Therapeutics (NASDAQ:XLO) stock fell 9.3% to $3.6 during Monday's after-market session. The market value of their outstanding shares is at $98.8 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) shares declined by 8.2% to $1.12. The company's market cap stands at $8.8 million.
  • Integer Holdings (NYSE:ITGR) shares fell 7.41% to $65.5. The company's market cap stands at $2.1 billion.
  • Heart Test Laboratories (NASDAQ:HSCS) stock declined by 6.39% to $2.2. At the close, Heart Test Laboratories's trading volume reached 2.6 million shares. This is 6319.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $18.3 million.
  • ASLAN Pharma (NASDAQ:ASLN) shares declined by 5.77% to $0.64. The market value of their outstanding shares is at $44.6 million.
  • Calithera Biosciences (NASDAQ:CALA) stock fell 5.66% to $0.42. The market value of their outstanding shares is at $2.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment